| Anti-platelet/anti-coagulants | |
---|---|---|
Variables | No (N = 55,746) | Yes (N = 18,218) |
NPDR | Â | Â |
Person-years | 307,299 | 133,609 |
Follow-up time (y), Mean ± SD | 5.51 ± 3.27 | 7.33 ± 3.16 |
  Event, n | 4413 | 1432 |
  Rate | 14.4 | 10.7 |
  cHR (95% CI) | 1 (Reference) | 0.75 (0.71, 0.79)*** |
  aHR (95% CI)a | 1 (Reference) | 0.78 (0.73, 0.83)*** |
PDR | Â | Â |
  Event, n | 32 | 13 |
  Rate | 0.10 | 0.09 |
  cHR (95% CI) | 1 (Reference) | 0.93 (0.49, 1.78) |
  aHR (95% CI)a | 1 (Reference) | 0.81 (0.42, 1.58) |
DME | Â | Â |
  Event, n | 48 | 14 |
  Rate | 0.15 | 0.10 |
  cHR (95% CI) | 1 (Reference) | 0.61 (0.33, 1.10) |
  aHR (95% CI)a | 1 (Reference) | 0.59 (0.32, 1.08) |